You are here

Takeda to make H5N1 avian flu vaccines with Baxter's help - Nikkei

Heads up! Takeda to make H5N1 avian flu vaccines with Baxter's help - Nikkei [Not to mention, in all likelihood -- an avian flu pandemic itself. Be afraid... be very afraid.] 18 Jun 2010 Japan's largest drugmaker Takeda Pharmaceutical Co will resume production of influenza vaccines after more than a decade, using technology from U.S. firm Baxter International Inc, the Nikkei business daily reported. The company that aims to begin shipments in 2014 would invest 30 billion yen ($329.9 million) to 50 billion yen, the daily reported. The Osaka-based firm will initially develop a vaccine to immunize against H5N1 avian flu, it said. [See: Baxter: The 'Lucky Larry' of swine flu -  Baxter Vaccine 'Oddities' By Lori Price 17 Jul 2009 Baxter files swine flu vaccine patent year ahead of outbreak --Baxter can take no more H1N1 flu vaccine orders --Baxter working on vaccine to stop swine flu, though admitted sending live pandemic flu viruses to subcontractor.]